HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome.

AbstractBACKGROUND & AIMS:
No standardised definition exists for acute, severe AIH (AS-AIH). However, rapid identification of AS-AIH and early corticosteroid therapy may prevent the need for liver transplantation (LT). We set out to determine the clinical outcomes of patients with AS-AIH presenting to our institution with particular focus on the role of corticosteroids.
METHODS:
Retrospective analysis of a prospectively collated database identified patients presenting with AS-AIH from 1999 to 2009. We defined AS-AIH as an acute presentation with an INR of ⩾1.5 at any time without histological evidence of cirrhosis.
RESULTS:
32 patients were identified with AS-AIH. Among the 32 AS-AIH patients 23 were treated with corticosteroids of whom 10 (48%) required LT, whilst all 9 untreated patients required LT (p = 0.01). Untreated patients demonstrated higher MELD scores at presentation (34 vs. 28 p = 0.01) and a non-significant decrease in episodes of sepsis but no difference in sepsis or mortality was observed between untreated or treated patients (11% vs. 26% p = 0.6 and 22% vs. 17% p = 0.99 respectively). Among treated patients, no difference in MELD scores was observed between responders or failures. Despite 59% undergoing LT, six deaths (19%) occurred.
CONCLUSION:
In a well characterised cohort of patients with AS-AIH, almost 60% required LT and 20% died. There was no difference in prognostic scores between steroid responders and failures and steroid exposure did not appear to jeopardise survival. Patients with AS-AIH should be considered for a trial of corticosteroids expediently whilst a thorough search for sepsis and assessment for LT should occur if clinical deterioration or encephalopathy develops.
AuthorsAndrew D Yeoman, Rachel H Westbrook, Yoh Zen, William Bernal, Thawab Al-Chalabi, Julia A Wendon, John G O'Grady, Michael A Heneghan
JournalJournal of hepatology (J Hepatol) Vol. 61 Issue 4 Pg. 876-82 (Oct 2014) ISSN: 1600-0641 [Electronic] Netherlands
PMID24842305 (Publication Type: Journal Article)
CopyrightCopyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Adrenal Cortex Hormones
  • Glucocorticoids
  • Immunologic Factors
Topics
  • Acute Disease
  • Adrenal Cortex Hormones (administration & dosage, adverse effects)
  • Adult
  • Early Medical Intervention (methods)
  • Female
  • Glucocorticoids (administration & dosage, adverse effects)
  • Hepatic Encephalopathy (etiology, prevention & control)
  • Hepatitis, Autoimmune (complications, diagnosis, drug therapy, mortality, physiopathology)
  • Humans
  • Immunologic Factors (administration & dosage, adverse effects)
  • Liver Function Tests (methods)
  • Liver Transplantation (statistics & numerical data)
  • Male
  • Prognosis
  • Retrospective Studies
  • Sepsis (etiology, prevention & control)
  • Serologic Tests (methods)
  • Severity of Illness Index
  • United Kingdom (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: